18375400

Source:http://linkedlifedata.com/resource/pubmed/id/18375400

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003851, umls-concept:C0024141, umls-concept:C0030705, umls-concept:C0035648, umls-concept:C0053358, umls-concept:C0151744, umls-concept:C0162596, umls-concept:C0332281, umls-concept:C0370188, umls-concept:C0442821
pubmed:issue	5
pubmed:dateCreated	2008-4-21
pubmed:abstractText	The main objective of this study was to clarify the role of aPLs in the pathogenesis of arteriosclerosis obliterans (ASO), ischaemic heart disease (IHD) and cerebral vascular disorder (CVD) in patients with SLE.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100883501
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Anticardiolipin, http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylserines, http://linkedlifedata.com/resource/pubmed/chemical/Prothrombin, http://linkedlifedata.com/resource/pubmed/chemical/beta 2-Glycoprotein I
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1462-0332
pubmed:author	pubmed-author:HidakaYY, pubmed-author:IwataniYY, pubmed-author:KanakuraYY, pubmed-author:KuratsuneHH, pubmed-author:MasudaYY, pubmed-author:NojimaJJ, pubmed-author:SuehisaEE, pubmed-author:TakanoTT, pubmed-author:WatanabeYY
pubmed:issnType	Electronic
pubmed:volume	47
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	684-9
pubmed:meshHeading	pubmed-meshheading:18375400-Adolescent, pubmed-meshheading:18375400-Adult, pubmed-meshheading:18375400-Aged, pubmed-meshheading:18375400-Aged, 80 and over, pubmed-meshheading:18375400-Antibodies, Anticardiolipin, pubmed-meshheading:18375400-Arteriosclerosis Obliterans, pubmed-meshheading:18375400-Autoantibodies, pubmed-meshheading:18375400-Biological Markers, pubmed-meshheading:18375400-Case-Control Studies, pubmed-meshheading:18375400-Child, pubmed-meshheading:18375400-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:18375400-Female, pubmed-meshheading:18375400-Humans, pubmed-meshheading:18375400-Logistic Models, pubmed-meshheading:18375400-Lupus Erythematosus, Systemic, pubmed-meshheading:18375400-Male, pubmed-meshheading:18375400-Middle Aged, pubmed-meshheading:18375400-Myocardial Ischemia, pubmed-meshheading:18375400-Phosphatidylserines, pubmed-meshheading:18375400-Prevalence, pubmed-meshheading:18375400-Prothrombin, pubmed-meshheading:18375400-Risk Factors, pubmed-meshheading:18375400-Statistics, Nonparametric, pubmed-meshheading:18375400-beta 2-Glycoprotein I
pubmed:year	2008
pubmed:articleTitle	Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
pubmed:affiliation	Laboratory for Clinical Investigation, Osaka University Hospital, 2-15 Yamadaoka, Suita, Osaka 565-0871, Japan. nojima@hp-lab.med.osaka-u.ac.jp
pubmed:publicationType	Journal Article